Axsome Therapeutics (AXSM) ROA US GAAP (year values) |
|||||||||
| 2022 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| ROA, % | ? | -56.5% | -56.5% | -40.7% | -50.5% | -26.6% | -26.4% | ||
| Changes by years, y/y, % | +92pp | 0pp | +16pp | -10pp | +24pp | -14.1% | |||
Axsome Therapeutics. ROA, %
Axsome Therapeutics. ROA, changes, pp
Axsome Therapeutics (AXSM) ROA US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| ROA, % | ? | -46.6% | -38.6% | -34.3% | -26.6% | -26.4% | -26.4% | |
| Changes by years, y/y, % | +8pp | +18pp | +21pp | +24pp | +20pp | |||
| Changes by quarters, q/q, % | +4pp | +8pp | +4pp | +8pp | +0pp | |||